to evaluate the effectiveness of Pfizer and J&J SARS-CoV-2 vaccines against laboratory-confirmed COVID-19 hospitalisation among risk groups targeted for vaccination
- Funded by Gates Foundation
- Total publications:0 publications
Grant number: INV-035995
Grant search
Key facts
Disease
COVID-19start year
2021Known Financial Commitments (USD)
$828,259Funder
Gates FoundationPrincipal Investigator
N/A
Research Location
South AfricaLead Research Institution
Wits Health Consortium (Pty) LtdResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
N/A
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
N/A